| Q28741189 | A comprehensive peptidome profiling technology for the identification of early detection biomarkers for lung adenocarcinoma |
| Q35174735 | A proteomics approach to the identification of plasma biomarkers for latent tuberculosis infection |
| Q90485563 | A systematic review of the applications of artificial intelligence and machine learning in autoimmune diseases |
| Q34069952 | APO-1/Fas gene: Structural and functional characteristics in systemic lupus erythematosus and other autoimmune diseases |
| Q91596819 | Application of machine learning in the diagnosis of axial spondyloarthritis |
| Q34284870 | Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS. |
| Q28071491 | Biomarkers of systemic lupus erythematosus identified using mass spectrometry-based proteomics: a systematic review |
| Q34020523 | Discovery of serum protein biomarkers in rheumatoid arthritis using MALDI-TOF-MS combined with magnetic beads |
| Q35057228 | Establishing serological classification tree model in rheumatoid arthritis using combination of MALDI-TOF-MS and magnetic beads |
| Q50908478 | Identification of potential biomarkers for systemic lupus erythematosus diagnosis using two-dimensional differential gel electrophoresis (2D-DIGE) and mass spectrometry. |
| Q33865598 | Identification of three new autoantibodies associated with systemic lupus erythematosus using two proteomic approaches |
| Q35047339 | Mass spectrum analysis of serum biomarker proteins from patients with schizophrenia |
| Q33550893 | Proteomic profiling of renal allograft rejection in serum using magnetic bead-based sample fractionation and MALDI-TOF MS. |
| Q30395380 | Screening for potential serum-based proteomic biomarkers for human type 2 diabetes mellitus using MALDI-TOF MS. |
| Q33644106 | Systemic lupus erythematosus diagnostics in the 'omics' era |
| Q34121793 | The Use of Principal Component Analysis in MALDI-TOF MS: a Powerful Tool for Establishing a Mini-optimized Proteomic Profile |